Label Changes for:
Avelox (moxifloxacin hydrochloride) Tablets and IV
October 2011
Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2011
Avelox (moxifloxacin hydrochloride) Tablets and IV
WARNINGS AND PRECAUTIONS
Central Nervous System Effects/ Disorders
- Convulsions and increased intracranial pressure (including pseudotumor cerebri) have been reported...
